Matsumoto K, Osakabe K, Katayama H, Yoshizawa N, Nagura Y, Harada M, Fujita T, Ohi H, Hatano M
Nephron. 1983;34(4):220-3. doi: 10.1159/000183019.
Cell-mediated immunity (CMI) was evaluated in 8 patients with focal glomerular sclerosis (FGS), 50 patients suffering from chronic mesangial proliferative glomerulonephritis without renal insufficiency and 24 healthy controls. The following parameters were measured: delayed skin reactivity to purified protein derivative, circulating lymphocytes, lymphocyte cell-surface markers (neuraminidase-treated sheep erythrocyte and erythrocyte-antibody-complement rosettes) and functional markers (mitogenic responses to concanavalin A and phytohemagglutinin). The FGS patients with nephrotic syndrome (NS) had a significant depression in CMI, characterized by decreased responses of the lymphocytes to both concanavalin A and phytohemagglutinin, impaired delayed hypersensitivity to purified protein derivative and a decreased proportion of T lymphocytes as compared with normal subjects. In contrast, the levels of all CMI parameters studied in FGS patients in remission and in patients with chronic glomerulonephritis with or without NS did not differ from normal subjects. Thus, the majority of FGS patients with NS demonstrated an impaired response in a CMI assay system. The possible significance of these phenomena in the pathophysiology of FGS is discussed.
对8例局灶性肾小球硬化(FGS)患者、50例无肾功能不全的慢性系膜增生性肾小球肾炎患者及24名健康对照者进行了细胞介导免疫(CMI)评估。检测了以下参数:对纯化蛋白衍生物的迟发型皮肤反应性、循环淋巴细胞、淋巴细胞表面标志物(神经氨酸酶处理的绵羊红细胞和红细胞 - 抗体 - 补体花环)以及功能标志物(对刀豆球蛋白A和植物血凝素的促有丝分裂反应)。患有肾病综合征(NS)的FGS患者存在显著的CMI抑制,其特征为淋巴细胞对刀豆球蛋白A和植物血凝素的反应降低、对纯化蛋白衍生物的迟发型超敏反应受损以及与正常受试者相比T淋巴细胞比例降低。相比之下,缓解期的FGS患者以及患有或未患有NS的慢性肾小球肾炎患者中所研究的所有CMI参数水平与正常受试者无差异。因此,大多数患有NS的FGS患者在CMI检测系统中表现出反应受损。讨论了这些现象在FGS病理生理学中的可能意义。